Sponsored by:
Unlock Faster, More Confident Biosimilar Development
Developing biosimilars requires rigorous analytical characterization to ensure safety, efficacy, and regulatory approval.
Developing biosimilars requires rigorous analytical characterization to ensure safety, efficacy, and regulatory approval. This exclusive Sartorius white paper explores how combining Octet® Biolayer Interferometry (BLI) with iQue® High-Throughput Cytometry delivers powerful orthogonal insights into ligand binding kinetics and live-cell functionality.
Inside, you’ll discover:
- How orthogonal techniques streamline biosimilar comparability studies
- Case studies on affinity, kinetics, and live-cell binding assessments
- Practical guidance for reducing variability and enhancing data confidence
- Strategies to accelerate development while meeting stringent regulatory standards
Whether you are in R&D, analytical sciences, or bioprocess development, this resource will help you optimize workflows and improve decision-making in biosimilar development.
